Riley E M, Olerup O, Troye-Blomberg M
Institute of Cell, Animal and Population Biology, University of Edinburgh, West Mains Road, Edinburgh EH9 3JN, UK.
Parasitol Today. 1991 Jan;7(1):5-11. doi: 10.1016/0169-4758(91)90076-z.
Owing to the demonstration that the immune response of inbred mice to some defined malaria antigens is influenced by the major histocompatibility complex (MHC), and the finding that only a minority of individuals living in malaria-endemic areas appear to recognize such antigens, there are fears that synthetic subunit malaria vaccines will be poorly immunogenic in a substantial proportion of the target population. Such fears have been reinforced by the results of the first two human malaria vaccine trials. In this review Eleanor Riley, Olle Olerup and Marita Troye-Blomberg summarize the experimental evidence for MHC-related genetic restriction of malaria immunity and discuss some alternative explanations for nonresponsiveness in populations living in malaria-endemic areas.
由于已证明近交系小鼠对某些特定疟疾抗原的免疫反应受主要组织相容性复合体(MHC)影响,且发现生活在疟疾流行地区的个体中只有少数人似乎能识别此类抗原,因此有人担心合成亚单位疟疾疫苗在很大一部分目标人群中免疫原性较差。前两项人类疟疾疫苗试验的结果进一步加剧了这种担忧。在这篇综述中,埃莉诺·赖利、奥勒·奥勒鲁普和玛丽塔·特罗耶 - 布洛姆伯格总结了疟疾免疫相关的MHC基因限制的实验证据,并讨论了疟疾流行地区人群无反应性的一些其他解释。